Product Description
Artemether + Lumefantrine is an artemisinin-based combination therapy (ACT) indicated for the treatment of acute uncomplicated plasmodium falciparum malaria, the most dangerous form of the disease.
The tablets have two key ingredients; artemether, which is a derivative of artemisinin, and lumefantrine (or benflumetol) an antimalarial drug. Artemether has been used by Chinese herbalists for more than a thousand years in the treatment of many illnesses. The combination of these two ingredients has led to one of the most successful malaria treatments of its kind. Artemether + Lumefantrine is a highly effective and well-tolerated malaria treatment, providing cure rates of up to 97%, even in areas of multi-drug resistance.
In 2002, artemether-lumefantrine tablets were added to the WHO's Essential Medicines list, an index of essential drugs which help guide the purchasing decisions of Member States and UN agencies.
Product Packaging
The Dosages available for Artemether + Lumefantrine Tablets are:
- Artemether 20 mg + Lumefantrine 120 mg
- Artemether 40 mg + Lumefantrine 240 mg
- Artemether 80 mg + Lumefantrine 480 mg
Artemether + Lumefantrine Tablets can be packaged as 6 tablets per box or as customer requirement.
